Home › Ovarian Epithelial Carcinoma › Missouri
Ovarian Epithelial Carcinoma clinical trials in Missouri
5 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Missouri.
Cities in Missouri
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Cox Medical Center South /ID# 274826, Springfield
- Mercy David C. Pratt Cancer Center /ID# 275655, St Louis
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Washington University School of Medicine in St. Louis, St Louis
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 15, 2026 · NCT06915025AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, Springfield
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0111, St Louis
RecruitingPhase 1
Ages 18 and older · Women · Updated Apr 7, 2026 · NCT04516447CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Washington University, St Louis
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.